Sevoflurane Insufflation vs Intravenous Sedation for Radiotherapy in Pediatric Patients
NCT ID: NCT04483258
Last Updated: 2020-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2020-07-05
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endotracheal Intubation With Sevoflurane in Surgical Pediatric Patients
NCT02429323
Intravenous Cannulation In Children During Sevoflurane Induction
NCT03851692
Intravenous Access Time in Pediatric Patients
NCT04190407
Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old
NCT04684238
Tolerance to Sevoflurane in Children Undergoing Repeated Drug Exposure
NCT04188782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sedation with Insufflation
Sedation induction via oxygen mask %8 sevoflurane and reducing %3 concentration after rediotherapy start
Sedation with sevoflurane insufflation
Induction with %8sevoflurane after adequate sedation reducing %3
İntravenous sedation
Midazolam+ Ketamine sedation
intravenous sedation
midazolam +ketamine + atropine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sedation with sevoflurane insufflation
Induction with %8sevoflurane after adequate sedation reducing %3
intravenous sedation
midazolam +ketamine + atropine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* chronic nausea and vomiting
* apnea history, pneumonia, asthma, bronchiolitis etc. respiratory tract infection or diseases
* cardiac disease
* kidney failure
* liver failure
* anticipated difficult airway
* metabolic diseases
* neurological or muscular diseases.
1 Year
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ismail aytaç
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
İsmail Aytac
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Anesthesiology Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E1-20-884
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.